Response to the Letter regarding "The additive impact of reduced symptom-to-door and door-to-balloon times on survival rates in acute ST-elevation myocardial infarction patients" [0.03%]
关于“缩短急性ST段抬高型心肌梗死患者症状至医院和入院至球囊时间对生存率影响”的来信回复
Jin-Man He,Yi-Tzone Shiao,Yu-Chen Wang et al.
Jin-Man He et al.
Beyond the right and duty to strike: Patient protection, proportionality, and ethical governance in collective physician action [0.03%]
超越罢工的权利与义务:患者保护、相称性及集体医生行动的伦理治理
Daniel Fu-Chang Tsai
Daniel Fu-Chang Tsai
Comment on "Dysregulation of chromatin remodeling genes predicts clinical outcomes in acute myeloid leukemia" [0.03%]
关于“染色体重塑基因的失调可预测急性髓系白血病的临床预后”的评论
Mohd Aadam Bin Najeeb,V K Manjunatha,A P Cardiliya
Mohd Aadam Bin Najeeb
Comment on "Enhancing thalassemia carrier detection: Advancing genetic screening strategies in prenatal care" [0.03%]
关于“提高地中海贫血携带者检测率:孕期护理中遗传筛查策略的改进”的评论
Vishal Khandelwal,Yagyavalkya Sharma,Deeksha Sharma
Vishal Khandelwal
Response to comment on "Enhancing thalassemia carrier detection: Advancing genetic screening strategies in prenatal care" [0.03%]
关于“提高地中海贫血携带者检测率:产前护理中遗传筛查策略的改进”的评论答复
Han-Ying Chen,Shin-Yu Lin
Han-Ying Chen
Refining the interpretation of JAK2-CHIP-associated parkinsonism: Phenotypic specificity, causal inference, and conceptual framing [0.03%]
JAK2-CHIP相关帕金森病的解释 refinement:表型特异性、因果推理和概念框架
Keyang Zhang,Wenhua Yu
Keyang Zhang
Comment on "Leukoaraiosis in patients with tirofiban before endovascular thrombectomy: A post hoc analysis of a multicentre randomized clinical trial" [0.03%]
关于“替罗非班在血管内血栓切除术前患者的白质异常改变——一项多中心随机临床试验的事后分析”的评论
Aashish A,Aravind P,Sindhu Subramani et al.
Aashish A et al.
Comment on "association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study" [0.03%]
关于“心血管-肾脏-代谢综合征与美国成年人的心血管、癌症和全因死亡率之间的关联:一项前瞻性研究”的评论
Rakesh Arya,Hemlata Shakya,Amit Kumar Mohapatra
Rakesh Arya
Comment on "Validating psychometric properties of generic quality-of-life instruments (WHOQOL-BREF (TW) and EQ-5D) among non-dialysis chronic kidney disease: Rasch and confirmatory factor analyses" [0.03%]
关于“验证非透析慢性肾脏疾病患者通用生命质量测量工具(WHOQOL-BREF(TW)和EQ-5D)的心理测量属性:Rasch分析与验证性因素分析”的评论
V C Punitha,Shankar Ram,Sugasri Sureshkumar et al.
V C Punitha et al.
Cardiovascular risk profiles among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Taiwan [0.03%]
台湾多发性硬化和视神经脊髓炎谱系疾病患者的血管风险因素档案
Chi-Ning Tsai,Yi-Chih Wang,Yi-Te Tsai et al.
Chi-Ning Tsai et al.
Background: While cardiovascular comorbidities are well described in multiple sclerosis (MS), they remain poorly characterized in neuromyelitis optica spectrum disorder (NMOSD). We aimed to identify cardiovascular risk as...